Kittelsen Sverre A C, Anthun Kjartan S, Goude Fanny, Huitfeldt Ingrid M S, Häkkinen Unto, Kruse Marie, Medin Emma, Rehnberg Clas, Rättö Hanna
Frisch Centre, Oslo, Norway.
SINTEF Health Research and NTNU, Trondheim, Norway.
Health Econ. 2015 Dec;24 Suppl 2:140-63. doi: 10.1002/hec.3260.
This article develops and analyzes patient register-based measures of quality for the major Nordic countries. Previous studies show that Finnish hospitals have significantly higher average productivity than hospitals in Sweden, Denmark, and Norway and also a substantial variation within each country. This paper examines whether quality differences can form part of the explanation and attempts to uncover quality-cost trade-offs. Data on costs and discharges in each diagnosis-related group for 160 acute hospitals in 2008-2009 were collected. Patient register-based measures of quality such as readmissions, mortality (in hospital or outside), and patient safety indices were developed and case-mix adjusted. Productivity is estimated using bootstrapped data envelopment analysis. Results indicate that case-mix adjustment is important, and there are significant differences in the case-mix adjusted performance measures as well as in productivity both at the national and hospital levels. For most quality indicators, the performance measures reveal room for improvement. There is a weak but statistical significant trade-off between productivity and inpatient readmissions within 30 days but a tendency that hospitals with high 30-day mortality also have higher costs. Hence, no clear cost-quality trade-off pattern was discovered. Patient registers can be used and developed to improve future quality and cost comparisons.
本文针对北欧主要国家,开发并分析了基于患者登记的质量衡量指标。先前的研究表明,芬兰医院的平均生产率显著高于瑞典、丹麦和挪威的医院,而且每个国家内部也存在很大差异。本文探讨质量差异是否能成为部分解释因素,并试图揭示质量与成本之间的权衡关系。收集了2008 - 2009年160家急症医院各诊断相关组的成本和出院数据。开发了基于患者登记的质量衡量指标,如再入院率、死亡率(院内或院外)以及患者安全指数,并进行了病例组合调整。生产率采用自抽样数据包络分析进行估计。结果表明,病例组合调整很重要,在病例组合调整后的绩效指标以及国家和医院层面的生产率方面都存在显著差异。对于大多数质量指标而言,绩效指标显示仍有改进空间。在生产率与30天内住院再入院率之间存在微弱但具有统计学意义的权衡关系,但30天死亡率高的医院往往成本也更高。因此,未发现明确的成本 - 质量权衡模式。患者登记可用于并加以改进,以提升未来质量和成本比较。